Status:
UNKNOWN
Increase Surveillance for Breast and Ovarian Cancers, Also to Determine Targeted Risk-reducing and Preventative Strategies
Lead Sponsor:
Data Collection Analysis Business Management
Collaborating Sponsors:
PAS Research Services
Conditions:
Hereditary Cancer
Eligibility:
All Genders
18-65 years
Brief Summary
Observational study is to increase surveillance for breast and ovarian cancers, also to determine targeted risk-reducing and preventative strategies.
Detailed Description
The general design of this study is collecting data and reviewing the Principal Investigators' (P.I.) Standard Operating Procedures (SOP) on BRCA testing and changes made to their specific SOP.
Eligibility Criteria
Inclusion
- Must be a Medical Practitioner
- Medical Doctor (MD)
- Doctor of Osteopathic (DO)
- Physician Assistant (PA)
- Advanced Practice Registered Nurse (APRN)
- Nurse Practitioner (NP)
- Must have a current standard operating procedure that includes obtaining/reviewing medical history and family medical history
Exclusion
- Government-funded insurance data cannot be included in the study.
Key Trial Info
Start Date :
October 17 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 17 2020
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT03319290
Start Date
October 17 2017
End Date
October 17 2020
Last Update
January 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
DCABM
Land O' Lakes, Florida, United States, 33558